Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)

Part of paid clinical trials in Dallas, Texas.

Sponsor
Baylor College of Medicine
Study ID
NCT05752448
Status
Recruiting

Conditions

  • Depressive Symptoms
  • Ovarian Neoplasm
  • Quality of Life

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • POSTCare Survivorship transition process — BEHAVIORAL
    Survivorship coaching intervention

Study Details

This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks after intervention.

Key Dates

Start date
Oct 1, 2023
Status verified
Mar 2026
Primary completion
Jul 1, 2026
Completion
Apr 15, 2027

Study Design

Enrollment
120 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Intervention group
    Group received care Using POSTCare process
  • No Intervention: Usual Care
    Group received usual care

Primary Outcome Measure

Quality of Life by FACT-O [ Time Frame: 12 Weeks ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
UT Southwestern Parkland Health and Hospital SystemDallasTexas75235
Carolina Salmeron
713-500-0147
Dan L Duncan Comprehensive Cancer Center at the O'Quinn Medical Tower at Baylor St. Luke's Medical CenterHoustonTexas77030
Lilian Moraes de Vasconcelos
713-798-4785
Harris Health Smith ClinicHoustonTexas77054
Lilian Moraes de Vasconcelos
713-798-4785

Find similar trials in Dallas, TX

Related Studies